Бельцевич Д.Г., Кузнецов Н.С., Солтдатова Т.В. В.В.Э. Инциденталома надпочечников. // Эндокринная хирургия. 2009. № 4(1). С. 19–23.
Fassnacht M., Arlt W., Bancos I., Dralle H., Newell-Price J., Sahdev A., Tabarin A., Terzolo M., Tsagarakis S., Dekkers O.M. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors // European Journal of Endocrinology. 2016. № 2(175). С. 1–34. DOI:10.1530/EJE-16-0467.
Mansmann G., Lau J., Balk E., Rothberg M., Miyachi Y., Bornstein S.R. The clinically inapparent adrenal mass: Update in diagnosis and management // Endocrine Reviews. 2004. № 2(25). С. 309–340. DOI:10.1210/er.2002-0031.
Berruti A., Baudin E., Gelderblom H., Haak H.R., Porpiglia F., Fassnacht M., Pentheroudakis G. Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up // Annals of Oncology. 2012. № 7(23). С. 131–138. DOI:10.1093/annonc/mds231.
Clark O.H., Ajani J.A., Benson A.B., Berlin J.D., Blaszkowsky L.S., Byrd D., Choti M.A., Doherty G.M., Engstrom P.F., Gibbs J.F., Heslin M.J., Kandeel F., Kessinger A., Kulke M.H., Kunz P., Kvols L., Olson J.A., Ratliff T.W., Salem R., Saltz L., Schteingart D.E., Shah M.H., Shibata S. Neuroendocrine tumors // JNCCN Journal of the National Comprehensive Cancer Network. 2009. № 7(7). С. 712–747. DOI:10.6004/jnccn.2009.0050.
Kloos R.T., Gross M.D., Francis I.R., Korobkin M., Shapiro B. Incidentally discovered adrenal masses // Endocrine Reviews. 1995. № 4(16). С. 460–484. DOI:10.1210/edrv-16- 4-460.
Bovio S., Cataldi A., Reimondo G., Sperone P., Novello S., Berruti A., Borasio P., Fava C., Dogliotti L., Scagliotti G. V., Angeli A., Terzolo M. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series // Journal of Endocrinological Investigation. 2006. № 4(29). С. 298–302. DOI:10.1007/BF03344099.
Young W.F. The Incidentally Discovered Adrenal Mass // New England Journal of Medicine. 2007. № 6(356). С. 601–610. DOI:10.1056/nejmcp065470.
Cawood T.J., Hunt P.J., O’Shea D., Cole D., Soule S. Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? // European Journal of Endocrinology. 2009. № 4(161). С. 513–527. DOI:10.1530/EJE-09-0234.
Fassnacht M., Dekkers O.M., Else T., Baudin E., Berruti A., De Krijger R.R., Haak H.R., Mihai R., Assie G., Terzolo M. European society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the study of adrenal tumors // European Journal of Endocrinology. 2018. С. 1–88. DOI:10.1530/EJE-18-0608.
Ahmed A.A., Thomas A.J., Ganeshan D.M., Blair K.J., Lall C., Lee J.T., Morshid A.I., Habra M.A., Elsayes K.M. Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management // Abdominal Radiology. 2020. С. 1–19. DOI:10.1007/s00261-019-02371-y.
Gross M.D., Shapiro B. Clinical review 50: Clinically silent adrenal masses // Journal of Clinical Endocrinology and Metabolism. 1993. № 4(77). С. 885–888. DOI:10.1210/jcem.77.4.8408461.
Terzolo M., Stigliano A., Chiodini I., Loli P., Furlani L., Arnaldi G., Reimondo G., Pia A., Toscano V., Zini M., Borretta G., Papini E., Garofalo P., Allolio B., Dupas B., Mantero F., Tabarin A. AME position statement on adrenal incidentaloma // European Journal of Endocrinology. 2011. № 6(164). С. 851–870. DOI:10.1530/EJE-10-1147.
Terzolo M., Bovio S., Reimondo G., Pia A., Osella G., Borretta G., Angeli A. Subclinical Cushing’s syndrome in adrenal incidentalomas // Endocrinology and Metabolism Clinics of North America. 2005. № 2(34). С. 432–439. DOI:10.1016/j.ecl.2005.01.008.
Terzolo M., Bovio S., Pia A., Conton P.A., Reimondo G., Dall’Asta C., Bemporad D., Angeli A., Opocher G., Mannelli M., Ambrosi B., Mantero F. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma // European Journal of Endocrinology. 2005. № 2(153). С. 307–315. DOI:10.1530/eje.1.01959.
Tauchmanovà L., Rossi R., Biondi B., Pulcrano M., Nuzzo V., Palmieri E.A., Fazio S., Lombardi G. Patients with subclinical Cushing’s syndrome due to adrenal adenoma have increased cardiovascular risk // Journal of Clinical Endocrinology and Metabolism. 2002. № 11(87). С. 4872–4878. DOI:10.1210/jc.2001-011766.
Morelli V., Masserini B., Salcuni A.S., Eller-Vainicher C., Savoca C., Viti R., Coletti F., Guglielmi G., Battista C., Iorio L., Beck-Peccoz P., Ambrosi B., Arosio M., Scillitani A., Chiodini I. Subclinical hypercortisolism: Correlation between biochemical diagnostic criteria and clinical aspects // Clinical Endocrinology. 2010. (73). С. 161–166. DOI:10.1111/j.1365-2265.2010.03794.x.
Mantero F., Terzolo M., Arnaldi G., Osella G., Masini A.M., Alì A., Giovagnetti M., Opocher G., Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. // The Journal of clinical endocrinology and metabolism. 2000. № 2(85). С. 637–644. DOI:10.1210/jcem.85.2.6372.
Kirkby-Bott J., Brunaud L., Mathonet M., Hamoir E., Kraimps J.L., Trésallet C., Amar L., Rault A., Henry J.F., Carnaille B. Ectopic hormone-secreting pheochromocytoma: A francophone observational study // World Journal of Surgery. 2012. № 6(36). С. 13820– 1388. DOI:10.1007/s00268-012-1488-1.
Мельниченко Г.А., Алексеев Б.Я., Бельцевич Д.Г., Стилиди И. С., Гордунова В.А., Кузнецов Н.С., Бохян В. Ю. К.А.А. Клинический рекомендации. Рак коры надпочечников (адренокортикальный рак).2020.